Curasan SRL
The score of Curasan shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +33 % Total assets +27 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Curasan's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 30,286 € | ||||
| Equity | 91,028 € | ||||
| Cash | 88,090 € | ||||
| EBITDA | 42,848 € | ||||
| Total assets | 103,974 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Jul 2026
- Year ended 31 Dec 2024filed on 15 Jul 2025
- Year ended 31 Dec 2023filed on 22 Jul 2024
- Year ended 31 Dec 2022filed on 02 Jul 2023
- Year ended 31 Dec 2021filed on 30 Jul 2022
Curasan's financial analysis
- Solvency87.5%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Curasan
Curasan's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0752.980.415
- VAT number
- BE0752980415
- Peppol
- Registered · 0208:0752980415 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Aug 2020
- Registered office
- 9630 Zwalm
- Latest accounts
- 2025 · filed on 15 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Curasan (SRL) has been based in Zwalm since 2020, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 30,286 € and equity of 91,028 €; its revenue is not published. Its solvency stands at 87.5%, above the median of its sector (44.2%).
Companies similar to Curasan
Companies in the same business, of comparable size and area, outside its group.
- Yascare Retail sale of pharmaceutical products Uccle · balance sheet 34,424 €
- Panax Retail sale of pharmaceutical products Wemmel · balance sheet 99,320 €
- BSB Pharma Retail sale of pharmaceutical products Berchem-Sainte-Agathe · balance sheet 118,927 €
- Kato VAN Vooren Retail sale of pharmaceutical products Dendermonde · balance sheet 88,886 €
- VAN Aelst Leonie Retail sale of pharmaceutical products Beernem · balance sheet 86,688 €
- Apocurae Retail sale of pharmaceutical products Kortemark · balance sheet 124,948 €
- Karbon Plus Retail sale of pharmaceutical products Diksmuide · balance sheet 127,790 €
- NT Farma Retail sale of pharmaceutical products Mouscron · balance sheet 56,255 €
Frequently asked questions about Curasan
What is the revenue of Curasan?
Curasan files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Curasan?
In Belgium, the VAT number is the company number prefixed with BE: BE0752980415 for Curasan, if the company is VAT-registered. Its company number (CBE) is 0752.980.415.
Where is the registered office of Curasan?
According to the CBE register, the registered office of Curasan is in 9630 Zwalm.
What is the equity of Curasan?
At the close of the 2025 financial year, the equity of Curasan amounts to 91,028 €, a solvency of 87.5% of total assets.
Who manages Curasan?
The register lists 2 active mandates at Curasan. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Curasan
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →